Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-009421
Filing Date
2022-04-08
Accepted
2022-04-08 12:01:56
Documents
2
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1515
2 ex24.htm EX-24 8914
  Complete submission text file 0001493152-22-009421.txt   12066
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 102 WOODMONT BLVD., SUITE 610 NASHVILLE TN 37205
Business Address
Makary Martin A. (Reporting) CIK: 0001921566 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35814 | Film No.: 22816066